Similar Papers

Paper Title
Journal
Date
Author
Overview of HIV drug resistance and its implications for China
Fu-Jie Zhang ... Jessica Haberer
Chinese Medical Journal | VOL. 119
Fu-Jie Zhang, et. al.Fu-Jie Zhang ... Jessica Haberer
01 Dec 2006
British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2005)
B Gazzard
HIV Medicine | VOL. 6
B GazzardB Gazzard
01 Jul 2005
British HIV Association guidelines for HIV‐associated malignancies 2008
M Bower ... C Cottrill
HIV Medicine | VOL. 9
M Bower, et. al.M Bower ... C Cottrill
01 Jul 2008
British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2006)
B Gazzard
HIV Medicine | VOL. 7
B GazzardB Gazzard
01 Nov 2006
View more papers

More From: JAIDS Journal of Acquired Immune Deficiency Syndromes

Paper Title
Journal
Date
Author
Resolution of Neuropsychiatric Adverse Events After Switching to a Doravirine-Based Regimen in the Open-Label Extensions of the DRIVE-AHEAD and DRIVE-FORWARD Trials
Graeme Moyle ... Rima Lahoulou
JAIDS Journal of Acquired Immune Deficiency Syndromes | VOL. -
Graeme Moyle, et. al.Graeme Moyle ... Rima Lahoulou
03 Jan 2025
Late re-engagement into HIV care among adults in the Swiss HIV Cohort Study
Andreas D Haas ... Gilles Wandeler
JAIDS Journal of Acquired Immune Deficiency Syndromes | VOL. -
Andreas D Haas, et. al.Andreas D Haas ... Gilles Wandeler
03 Jan 2025
Associations between gender and solicited adverse events after passive infusion of VRC01 or placebo in HVTN 704/HPTN 085
Deborah A Theodore ... Magdalena E Sobieszczyk
JAIDS Journal of Acquired Immune Deficiency Syndromes | VOL. -
Deborah A Theodore, et. al.Deborah A Theodore ... Magdalena E Sobieszczyk
16 Dec 2024
Trends in hospital readmissions among adults with and without HIV in the US, 2010-2020
Xianming Zhu ... Aaron A.R Tobian
JAIDS Journal of Acquired Immune Deficiency Syndromes | VOL. -
Xianming Zhu, et. al.Xianming Zhu ... Aaron A.R Tobian
04 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.